INTRODUCTION
The diagnostic detection of immunological abnormalities in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) originated in 1947 when Kabat (1942) demonstrated the elevated IgG levels often seen in the disorder. Since then a number of additional observations have extended the initial findings. The introduction of a simple technique of agar electrophoresis (Wieme, 1959) led to the observation that the IgG elevation was electrophoretically restricted (oligoclonal banding -OB) (Lowenthal et al., 1960) . There is some reason to think that the immune response exemplified by OB is a specific one. The antibody response seen in the C S F shows electrophoretic restriction, an altered kappa-lambda light chain ratio (Link et al., 1970) and IgG subclass restriction (Vandvik et al., 1976) . Although the nature of the antibody response remains uncertain, its presence is of diagnostic usefulness in the evaluation of patients with multiple sclerosis and other inflammatory neurological diseases.
In spite of much evidence that C S F electrophoresis is valuable in the diagnosis of MS, neurological centers in this country have been slow to adopt this methodology. The present paper details the experience with C S F electrophoresis in the Multiple Sclerosis Clinic at University Hospital, London, Ontario, for the last 4 years. The diagnostic value of C S F electrophoresis shown by other workers is confirmed. Patients were divided into groups of "C.D.M.S.", "possible MS" (which included Rose's possible and probable MS) - (Rose et al., 1976) and "non-MS". Possible MS was loosely interpred as including cases in which MS was a diagnostic possibility although other diagnoses were under consideration and in many instances more likely. Some patients known to the authors with a clinical status of "possible MS" at the time of CSF electrophoresis, but who subsequently fulfilled criteria for CD.M.S. during the period of the study were included in the CD.M.S. group. (This small group of patients is presently under study to determine the prognostic usefulness of CSF electrophoresis in possible MS).
METHODS
Cerebrospinal fluid was obtained by lumbar puncture and after centrifugation was concentrated using Minicon B15 filters (Amicon Corporation, Lexington, Mass.), or by negative pressure dialysis. CSF protein was determined by TCA precipitation (Meulemans, 1960) and samples were concentrated to between 40 and 100 times the original volume so that the total protein of the concentrated CSF approximated 2-3 gm%. The first 650 samples were done by cellulose acetate electrophoresis coupled with a photographic enhancement technique as previously described (Paty et al., 1977) . The last 350 samples were done by agarose gel electrophoresis using either a commercial electrophoresis system (Panagel -Millipore Corporation, Bedford, Mass.) or with agarose plates prepared in the author's lab using high electroendosmotic agarose (Seakem -Marine Colloids, Rockland, ME). The method for running electrophoresis, drying gels and staining is as previously described (Johnson et al., 1977) (LKB application note #310 -LKB, Bromma, Sweden). Gels were evaluated visually for the presence of oligoclonal banding. This was done without knowledge of the diagnosis except in the case of the authors' own patients. Gels were considered positive if two or more bands were present in the gammaglobulin region excluding those commonly found in control CSF (gamma trace protein) (Link, 1967) and (with agarose) a band between the origin and gamma trace protein (Laurell, 1972) . For some studies an anti-IgG overlay technique (Arnaud et al., 1977) was used for immunochemical confirmation of the immunoglobulin nature of bands. Isoelectric focusing was performed using gels made in the authors' laboratory immediately prior to use (LKB application note #75, Ebers et al., 1979 Electrophoreses which were technically inadequate were not included in the series. This usually related to insufficient CSF being supplied or to unusually low protein levels. RESULTS Our results confirm previous findings that CSF electrophoresis in C.D.M.S. is of high diagnostic yield (Laterre et al., 1970) . It can be seen from the overall results of cellulose acetate and agarose gel electrophoresis that oligoclonal banding was found in 92.8% of 248 patients with C.D.M.S. (Table 1) . Agarose electrophoresis alone yielded 95.4% positive O.B. in 103 patients ( Table 2 ). The incidence of O.B. in "possible MS" was substantially lower than that in C.D.M.S. (38.1% of 283 patients) in the combined series.
The variety of diagnoses seen in patients with negative O.B. is in Tables  3 and 4 . These largely reflect a cross section of patients undergoing lumbar puncture or myelography. Table 5 lists the diagnoses in patients having oligoclonal banding in the CSF with neurological disorders other than MS. We have divided these 36 patients into two groups, one associated with local immune response or serum bands, and the other not associated with either of these two features. Of the 36 non-MS patients with O.B. 19 fell into the former group and the presence of O.B. in CSF appeared to reflect a local CNS immune response or passive diffusion of bands from the serum. For the remaining 17 patients we have no explanation for the presence of O.B.
276-NOVEMBER 1980
CSF Electrophoresis in M. S. The results with agarose were slightly better than those with cellulose acetate reflecting a slight increase in sensitivity with this method. As previously reported (Ebers et al., 1979) isoelectric focusing, agarose gel electrophoresis and cellulose acetate electrophoresis all gave high yields in CD.M.S. in decreasing order of sensitivity. Agarose electrophoresis in 6 MS CSF, one control CSF and normal serum is seen in the Figure. (SandbergWolheim, 1975) . Of relevance in this regard is the fact that the banding pattern once present in MS tends to remain stable (Vandvik, 1977) .
Our own observations on this point have been hampered by improving the methodology over the course of time which has made it difficult to exclude the possibility that prior absence of O.B. was simply due to technical factors.
The appearance of O.B. in disorders other than MS clearly demonstrates that the presence of oligoclonal banding in CSF is not diagnostic of MS. The phenomenon of oligoclonal banding (which appears to represent the activation of relatively few clones of immunoglobulin producing cells) may be seen in a variety of disorders in addition to MS. These disorders are in general unlikely to cause diagnostic confusion. In a single case in this series a patient with the Arnold-Chiari malformation was thought to have clinical MS partly on the basis of a suspicious CSF electrophoresis, but follow-up led to the correct diagnosis.
The importance of concomitant serum paraprotein abnormalities were reflected in the CSF. We have not done the serum electrophoresis routinely until the most recent 350 samples.
Seventeen patients with "non-MS" O.B. are difficult to explain. We have observed the persistence of O.B. in an occasional patient with herpes simplex encephalitis and a similar phenomenon has previously been reported for mumps meningo-encephalitis (Vandvik et al, 1978) . It is possible that bands in these patients could have represented the residua of a remote viral infection of the nervous system. It seems an unlikely explanation however, for the majority of these non-MS positives.
Because immunofixation was not routinely used in this study some oligoclonal bands may not have been immunoglobulin and accordingly it is possible that routine use of an anti-IgG overlay method might reduce the frequency of non-MS positives. However, this remains to be seen.
Recently we have employed an antiIgG peroxidase overlay method to determine that certain bands are immunoglobulin, but this was not routinely used. The results given in Tables 1 through 5 were obtained without this modification. Because of the slightly better results of the agarose method and the lack of necessity for photographic enhancement our laboratory now uses the agarose method as a routine.
The data from this large series confirms information gathered by numerous individuals on the diagnostic value of CSF electrophoresis in MS. The frequency of O.B. in this study is very high although similar results have been reported (Olsson et al., 1976; Laurenzi et al., 1978) . We have been concerned that the high frequency of O.B. in our study reflects to some extent the large number of well developed cases included in this series. There is a paucity of data on how often O.B. develops in the course of MS to indicate how important the duration of the disease is to the frequency of O.B.
Nevertheless, the frequency of abnormalities has been so high as to substantially affect our clinical practice. The presence of O.B. in CSF has frequently led to the omission of contrast procedures such as myelography which would ordinarily have been done. Furthermore, the absence of O.B. when it is expected has occasionally led to the identification of another non-MS diagnosis. We think it in order to reconsider the diagnostic criteria for MS.
Heretofore, the accepted diagnostic criteria for MS (Schumacher et al., 1965) have been solely clinical. The accuracy of these clinical diagnostic criteria has never been established. There is no question that numerous individuals may fulfill the diagnostic criteria for MS and at autopsy be proven to have another disorder.
Heavy reliance on subjective interpretations are implicit in the criteria, especially in the caveat that the disease cannot be better explained by another disorder. In the absence of careful autopsy data arguments on the relative merits of clinical criteria and CSF electrophoresis become circular. For research studies on MS we favor the view that only patients with O.B. be included. It is worth pointing out that no autopsy study evaluating the reliability of the clinical criteria has been performed or is likely to be in the near future. Our own material included 9 autopsy proven cases of MS seen during the last 4 years. All of these patients have shown O.B. in life or in electrophoresis of post-mortem CSF. However, an additional autopsied patient with "transitional sclerosis" did not have oligoclonal banding. One autopsy case of "clinical MS" was found to have a neuro-enteric cyst embedded in the thoracic cord. There was no evidence of multiple sclerosis. In this case O.B. was negative on postmortem CSF obtained at cisternal puncture.
We have been interested to determine if the results of agarose gel electrophoresis can be improved with the use of isoelectric focusing (IEF). IEF is a more sensitive technique than agarose gel and frequently separates bands, which are apparently single on agarose, into several distinct ones (Ebers et al., 1980) . It has been shown that single antibodies secreted by cloned myeloma cells may be resolved into a number of bands probably reflecting post-synthetic differences among antibody molecules. We have found IEF especially useful for those cases in which agarose electrophoresis was equivocal or negative as suggested by Laurenzi (1978) . No case has been found in which the agarose gel electrophoresis was positive and the IEF negative. Interestingly, the cases in which IEF was positive 
The method of concentration of C S F used in this study was adequate. In a previous study concentration of C S F was varied so that a constant amount of immunoglobulin per cent was applied to the gel (Link, 1973) . Since the IgG level in MS C S F is often much higher than that seen in controls, this approach may require a very high concentration of non-MS C S F or less concentration of MS C S F . We have not found this an advantage. We now use the quantity of albumin (an index of barrier function) as a standard for protein applied to gels. Albumin and IgG levels may be determined simultaneously by rocket Immunoelectrophoresis as described by Tourtellotte (1969) . Since nephelometric determinations of IgG and albumin levels may be performed in many routine hospital laboratories, rapid measurement of IgG and albumin may be obtained with this method. Nevertheless, as shown in this study adequate results can be obtained simply with total protein.
C O N D U C T I O N M E D I U M
Some variability has been noted in the commercial agarose plates which leads to occasional difficulties. However, on the whole the commercial apparatus and gels have been adequate. The main advantages of the commercial system relate to the narrow application points enabled by the slotted masks and the fact that the agarose is bound to a plastic backing for ease of handling.
For gels poured in our own lab we have used high electroendosmotic agarose. This increases cathodal migration of IgG somewhat and may aid in the separation of oligoclonal bands.
We have found it important to run normal serum and C S F samples with each electrophoresis as standards. Paired sera and CSF's should be run simultaneously to identify C S F bands positively originating from the serum compartment.
C O N C L U S I O N S
The demonstration of oligoclonal banding by C S F electrophoresis is of substantial diagnostic value in the evaluation of M S . Good results may be obtained using easily adaptable commercial electrophoresis systems. These are within the capability of the average hospital biochemistry laboratory. In this study 92.8% of patients with clinically definite MS had oligoclonal banding. Eight percent of non-MS neurological disorders also demonstrated oligoclonal banding. The majority of these disorders were those associated with local C N S immune response or serum bands. The C S F electrophoresis appears to have a sufficient diagnostic yield to warrant inclusion in the criteria for the diagnosis of MS.
NOTE: This project was funded by a grant from the Physicians' Services Incorporated Foundation. ADDENDUM: C.D.M.S. patients in this series had a mean duration of disease at the time of CSF study of 11 years, (median 7 years)
